Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer

Fig. 5

The combination of METTL3 levels and CD33+ MDSC numbers displayed a prognostic value for poor survival of CC patients. a, b Kaplan–Meier curves showing the relationship of DFS (P < 0.001, n = 197) and OS (P < 0.001, n = 197) of CC patients and the combination of METTL3 levels and CD33+ MDSC number in 197 patients. c, d Kaplan–Meier curves showing the relationship of DFS (P = 0.063, n = 197) and OS (P = 0.037, n = 197) of CC patients and the combination of METTL3 levels and CD33+ MDSC number in 127 early-stage patients. e, f Kaplan–Meier curves showing the relationship of DFS (P < 0.001, n = 197) and OS (P < 0.001, n = 197) of CC patients and the combination of METTL3 levels and CD33+ MDSC number in 70 patients with advanced-stage CC

Back to article page